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Abstract
A trial has been performed on 201 dairy
cows from two Italian commercial herds in
order to verify whether the mitigation of a rec-
ognized negative energy balance (NEB) by a
therapeutic mean may influence the incidence
of peri-partum diseases. All animals were test-
ed for beta-hydroxybutyrate (b-HOB) and
non-esterified fatty acids (NEFA) three times a
week from 2 weeks before the expected due
time to 2 weeks after calving. Animals whose
blood levels were above b-HOB>1.2 or
NEFA>0.5 mmol/L were declared POSITIVE and
then split in two groups. Group T animals
(n=57) were treated with a glycogenic treat-
ment (ENERGAN KETOSIS, Virbac). The treat-
ment was repeated daily as long as biochemi-
cal values remained abnormal. Group C ani-
mals (n=48) served as untreated controls.
Animals with values within the physiological
range over the study period were said NEGA-
TIVE (n=96). This study confirmed that ani-
mals presenting excessive b-HOB or NEFA
concentrations show a higher risk to get sick
during the study period (P<0.05), the major
risk being clinical ketosis (P<0.01) and in a
lesser extend retention of the placenta
(P=0.09). The application of a glycogenic
treatment did not show an impact on blood
metabolite levels due to huge individual differ-
ences. However, application of the treatment
for an average duration of 5 days tends to
reduce the incidence of all the diseases related
to a NEB. Moreover, untreated control animals
were more likely to get dislocation of the abo-
masum (P<0.05) than NEGATIVE animals
whereas treated animals were not.
Introduction
During the past two decades, considerable
progress has been made in understanding the
physiology of the transition towards lactation
in dairy cows (Drackley et al., 2006). During
the transition period, and particularly during
the two weeks following parturition, dairy cows
are faced with an inevitable energy deficit
(NEB), which will play a crucial role for the
remainder of lactation (Wensing et al., 1997). 
Relations have already been reported
between the duration and severity of periods of
NEB, on the one hand, and the incidence of
certain diseases, on the other hand, particular-
ly digestive disorders and lameness (Collard et
al., 2000). Between 30 and 50% of cows may
suffer from a metabolic or infectious disease
just before or after calving (Ingvartsen et al.,
2003; LeBlanc, 2010). The disorders associated
with inadequate energy intake predispose
cows to metabolic or infectious diseases such
as milk fever (MF), endometritis (MET), ace-
toneamia (CK), displaced abomasum (DA) and
retention of the placenta (RP) (Esposito et al.,
2014). The reciprocal relations between the
disorders referred to above have long since
been demonstrated (Morrow, 1976; Curtis et
al., 1985; Peeler et al., 1994; Heuer et al., 1999;
Chapinal et al., 2011). Uncomplicated CK, RP
MET and MF are risk factors for DA (Shaver,
1997).
It is now an accepted fact that an extreme
rate of mobilisation of fatty tissue is related to
a high incidence of metabolic diseases
(Drackley, 1999). Such intense lipomobilisa-
tion leads to an elevation in the serum concen-
tration of non-esterified fatty acids (NEFA)
and then to their uptake by the liver, and to the
accumulation of triglycerides in the latter. This
accumulation of fatty acids in the liver predis-
poses the cow to the induction of ketosis
accompanied by an elevation of serum beta-
hydroxybutyrate (b-HOB). Various authors
have already demonstrated that the blood lev-
els of b-HOB, NEFA and calcium (Ca) are
closely correlated with the incidence of produc-
tion diseases ( Hoedemaker et al., 2004; Goff,
2006; Stengärde et al., 2010; Chapinal et al.,
2012, 2011). 
The idea of compensating a NEB by the daily
administration of propylene glycol or glycerol,
starting from the last days of gestation and for 2
or 3 weeks after calving, is inconsistently prac-
ticed in modern dairy farms although it  has
already been experimented by various authors
(Miettinen, 1995; Formigoni et al., 1996;
Hoedemaker et al., 2004; Castañeda-Gutiérrez et
al., 2009; Lomander et al., 2012; McArt et al.,
2011). In addition to the practical and economic
constraints involved, and although propane 1,2-
diol is a permitted additive for animal feed in
Europe (EU Regulation 892/2010) and in the
United States, the adjunction of a non-natural
additive to the ration of dairy cows may be ques-
tioned. It may be judicious to use propylene gly-
col sparingly in the form of a prescription drug.
Some authors have already suggested the strate-
gic use of blood tests for the detection of animals
suffering from sub-clinical ketosis. The meas-
urement of NEFA should be used during the last
week of gestation and that of b-HOB  during the
first week post-partum (McArt et al., 2013).
The purpose of this study was to verify
whether systematic screening for sub-clinical
ketosis during the transition period (2 weeks
before and after calving) via the measurement
of the blood levels of b-HOB and NEFA, fol-
lowed by ad hoc treatment with propylene gly-
col, calcium propionate, betaine, niacin and
molasses and by selective treatment with calci-
um for as long as necessary to restore the nor-
mal values of these metabolites could have an
impact on the morbidity and incidence of MF,
RP, MET and DA during the immediate post-
partum period.
Materials and methods
The study was conducted in specialised
dairy farms in the region of Milano (Italy) who
had volunteered to take part in the trial. The
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farms were monitored by the same veterinary
practice and were located close to the laborato-
ry. All samplings points aimed to monitor the
transition period disturbances and were per-
formed under informed consent of the breed-
ers. Blood (10 mL) were taken from all the ani-
mals during or just after the morning meal as
animals were restrained for feeding, placed in
plain tubes and immediately delivered to the
laboratory. After centrifugation (2200 g X 10
min), serum was separated and analysed soon
after. Concentration of NEFA, b-HOB and calci-
um were measured by means of an automated
spectrophotometer (ILAB 300 plus;
Instrumentation Laboratory Spa, Milano, Italy)
using commercially available kits: NEFA
(Acetyl CoA synthetase colorimetric method,
Randox Laboratories Ltd., Crumlin, Co.
Antrium, UK) and b-HOB (D-3-
Hydroxybutyrate dehydrogenase method,
Randox Laboratories Ltd.), calcium (orthocre-
softaleine method; Instrumentation Laboratory
Spa).
The investigating veterinarian was respon-
sible for evaluating the annual incidence of
DA, RP, MF, MET and CK, one of which must
exceed 5, 15, 10, 10, 10% respectively.
Monitored animals were gestating dairy
cows. The size of the population was set at
about 200 animals. Animals were recruited
according to their foreseeable due date. No
animal was excluded a priori if gestation was
confirmed. Animals were maintained in per-
manent open housing, with individual bedding
cubicles. Towards the end of gestation, the ani-
mals were fed a diet of corn silage, straw and
concentrates. Glucogenic treatments were pro-
hibited and their use was grounds for exclu-
sion.Follow-up protocol
The animals were included starting at 2
weeks before the presumed date of parturition.
The study was continued until 15 days after
calving. A computerised data-collection form
indicated, for each animal, the dates of the
blood samples and the tests to be performed.
Sampling on day d±1 was tolerated, according
to the day of the week on which the animals
were included. Overall, blood samples were
taken 3 times a week from the animals moni-
tored. The results from the laboratory were
available late in the afternoon. The sampling
plan was as follows: 
First week of the study (14-7 days pre-par-
tum): all the animals had samples taken for
the measurement of b-HOB and NEFA.
Second week of the study (7 days pre-par-
tum up to the date of parturition), all the ani-
mals had samples taken for the measurement
of b-HOB, NEFA and Ca.
Third week of the study (first week post-par-
tum): all the animals were monitored for b-
HOB and Ca.
Fourth week (final sample) of the study (7-
15 days post-partum): all the animals were
monitored for b-HOB.Treatment given to the animals
Animals showing levels of b-HOB>1.2
mmol/L or of NEFA>0.5 mmol/L for the first
time were considered as POSITIVE animals. As
soon as results were available (within 8 to 12
hours), positive animals with an odd-num-
bered ear tag (last digit) were included in the
treatment group (group T) and were then
drenched  on a daily basis, with a glucogenic
medication containing propylene glycol (122
g), calcium propionate (11 g), betaine (7 g),
niacin (5 g) and molasses (~150 g) until the
biological values returned to normal (ENER-
GAN KETOSIS; Virbac S.A., Carros, France).
Other POSITIVE animals (even-numbered ear
tag) were left untreated and served as controls
(group C). Animals with b-HOB and NEFA
within the physiological range all over the
study period were declared NEGATIVE (Figure
1). Hypocalcemia, even if mild, was judged to
be a potential bias, liable in itself to jeopardise
the possible beneficial effect of the glucogenic
treatment. In an attempt to control it, calcium
was therefore administered selectively at the
time of parturition. The effects of the two
treatments were therefore merged. Positive
animals were thus equipped with a parturition
detector (VEL’PHONE, Medria, Châteaubourg,
France), in order to be able to treat them with
calcium in due time. When the parturition
detector made it possible to predict the hour at
which calving would occur, the animals
involved received 41.4 g of elemental calcium
12 h prior to parturition and 12 hours after it,
in the form of a commercial preparation con-
taining calcium propionate and chloride asso-
ciated with disodium phosphate and magne-
sium oxide (ENERGAN CALCIUM, Virbac).Data collection and processing
The occurrence of DA, MF, RP, CK and MET
during the study period was recorded for all the
animals in order to compare the incidence of
those diseases in each group.
While 80% of calving in artificially insemi-
nated Holstein cows occur 272±10 days after
insemination (Matthews and Morton, 2012),
predicting the exact date of parturition in an
individual remains problematic. As a result,
and without even taking into account the
recording mistakes regarding the actual date
of insemination, the date of the animals’ incor-
poration into the follow-up may be somewhat
distant from the date of calving. In addition,
since blood samples were taken in each animal
about 1 out of every 3 days (d±1), the number
of values able to be processed for each of the
three groups and for each day prior to calving
may be expected to possibly be small.
Moreover, in cows, the physiological distribu-
tion of b-HOB serum concentrations is very
broad (<0.4 to >1.2 mmol/L) (Enjalbert et al.,
2001). The combination of such phenomena
was expected to lead to a significant loss of sta-
tistical power over the pre-partum period.
However, to do justice to the important work of
blood sample collection and testing, blood
chemistry results of experimental groups has
been processed for a preliminary comparison.
Pre-partum samples from 3 consecutive days
were thus grouped together beginning on day -
29 (±1 day) to day -2 (±1 day), resulting in 10
periods of 3 days. Cows that calved more than
30 days after inclusion or with no blood tests
                                                                                Production diseases prevention in cattle
Figure 1. Study design and experimental groups, group definition and size (n). POSI-
TIVE animals are animals with β-HOB or NEFA values out of the physiological range
(>1.2 or 0.5 mmol/L respectively). POSITIVE animals are therefore treated with a gluco-
genic medicine (group T) or left untreated (group C), according to final digit of their ear
tag (even number=C; odd number=T). Positive animals were also drenched with an oral
calcium solution at calving time.
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during the pre-partum period were excluded
from this exploratory analysis.
The data were analysed at DIVET using the
Analyse-it software (Analyse-it Ltd, Leeds,
UK). The relative incidence of the diseases
monitored were compared via a chi-2 test.
Results
Two dairy farms and 201 animals were
included in this trial.Application of glucogenic treat-ments
Fifty-seven animals received glucogenic
treatment during the study. The average treat-
ment duration was 4.6 days, involving one dose
per day of the commercial product. All treat-
ment took place before parturition. Forty-three
animals (75%) did not require any other treat-
ment. Ten animals relapsed and had to be
treated again for a mean duration of 6.2 days.
The median day for the application of the
glucogenic treatment was 6 days before calving
(IQR=10 days).Prevalence of the diseases moni-tored
During the study period 57 (28.3%) experi-
mental animals got one of the monitored dis-
eases (Table 1). The most common disease
was CK (18.9%) then RP (9.9%), DA (4.5%)
and MF (2.0%). No puerperal metritis (MET)
was reported in any group. All cases were diag-
nosed or confirmed by the veterinary surgeon
responsible for the two farms. RP and MF diag-
nostic is regarded as obvious for an experi-
enced veterinarian. CK diagnosis is based on
lack of appetite, lack of rumination, milk yield
decrease, depression and positive result to
urine or milk test. DA diagnostic relies on sim-
ilar observations and a positive left flank aus-
cultation (typical ping). All DA were left dis-
placement of abomasum.
A comparison between NEGATIVE and con-
trol animals on one side, and NEGATIVE and
treated animals on the other side, revealed the
following points: 
i) Positive animals (test+) were significantly
(P<0.01) more SICK than NEGATIVE animals
(test-), showing significantly more CK
(P<0.01) and were possibly at increased risk to
show RP (P=0.093).
ii) Animals belonging to group C (tests+,
untreated) were significantly (P<0.01) more
SICK than NEGATIVE animals (test-), present-
ed significantly more CK (P<0.01), more DA
(P<0.05) and were possibly at increased risk to
show RP (P=0.099).
iii) Animals belonging to group T (tests+,
treated) were significantly (P<0.01) more
SICK than NEGATIVE animals and presented
significantly more CK (P<0.05). Regarding DA
and other conditions, differences were not sig-
nificant.
There was no significant difference
between group C and group T animals for any
of the monitored conditions.
The median day (and IQR) for the diagnos-
tic of DA and CK were 11 (IQR=7) and 5
(IQR=7) days after calving respectively.Blood chemistry resultsDispersion of calving
The median time elapsing between the
inclusion of the animals and calving was 18
days, 50% of cows having calved between 15
and 21 days after enrolment. The rest of the
animals calved between 49 to 22 and 14 to 0
days after inclusion. Dispersion of blood chemistry results
Although 2459 blood tests were performed
on the animals, the number of samples avail-
able for each day prior to calving ranged from
59 (NEFA, day -12) to 0 (Ca, day -27). Pre-par-
tum period samples were grouped together as
explained in the Materials and methods sec-
tion. A table indicating the final number of ani-
mals for which statistical analysis is possible
may be consulted in Table 2. From d-29 (±1d)
to d-14 (±1d) most of the animals remained
NEGATIVE (data not shown) whereas few POS-
ITIVE cows were spit into treated and non-
treated animals.
The bHOB blood concentration mean and
median (3 d periods) gently increased over the
pre-partum period (Figure 2), always remain-
ing below the action threshold (1.2 mmol/L). In
contrast dispersion of results increased dra-
matically over the pre-partum period.
Calving dispersion and blood result disper-
sion have been judged being a major difficulty
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Table 1. Statistical comparison (χ2) of the distribution of cows affected by monitored diseases (sick or with DA, MF, RP, CK) or by a
specific condition in NEGATIVE animals (b-HOB<1.2 and NEFA<0.5 mmol/L, all tests ) or in POSITIVE and treated animals (group
T) or in POSITIVE and untreated controls (group C). 
                                                                    Overall              Negative                   Positive                Positive           Positive vs        Negative animals              Negative animals
                                                                                                 animals                    animals                 animals              negative                      vs C                                     vs T
                                                                                                                                        (C)                         (T)                  animals                                                                        
                                                                   Affected/            Affected/                  Affected/              Affected/                                               P-values
                                                                 non affected     non affected           non affected        non affected                                                   
Sick                                                               57/144                   15/81                         22/26                      20/37                  <0.001                      <0.001                                   0.006
                                                                      (28.3)                  (15.6)                       (45.8)                    (35.1)                                                                                                      
Displaced abomasum (DA)                     9/192                  feb-94                      mag-43                   feb-55                  0.116                         0.028                                    0.593
                                                                       (4.5)                    (2.1)                        (10.4)                     (3.5)                                                                                                       
Milk fever                                                     4/197                  feb-94                      gen-47                   gen-56                  0.928                         1.000                                    0.887
(MF)                                                             (2.0)                    (2.1)                         (2.0)                      (1.8)                                                                                                       
Retention of the placenta                       20/181                  giu-90                       lug-41                    lug-50                   0.093                         0.099                                    0.196
(RP)                                                              (9.9)                    (6.2)                        (14.6)                    (12.3)                                                                                                      
Clinical ketosis                                          38/163                  set-87                        17/31                     dic-45                 <0.001                      <0.001                                   0.042
(CK)                                                             (18.9)                   (9.4)                        (35.4)                    (21.1)                                                                                                      
In brackets percentage values. P values lower than 0.05 are significant.
D
ow
nl
oa
de
d 
by
 [P
oli
tec
nic
o d
i M
ila
no
 B
ibl
] a
t 0
7:1
4 2
5 M
arc
h 2
01
6 
                                               [Ital J Anim Sci vol.14:2015]                                                               [page 541]
for a correct statistical analysis, regardless of
validity conditions of tests such as ANOVA, and
thus no relevant conclusion was expected.
Therefore, authors gave up to further inappro-
priate statistical comparison between experi-
mental groups. Additionally, analysis of NEFA
and Ca results leaded to similar conclusions
with even smaller groups for Ca interpretation.
Although 4 milk fever have been recorded, no
worrying hypocalcaemia was detected and not
any cow was given a prophylactic treatment
with calcium.
Discussion
This study was conducted in order to verify
whether it would be possible to decrease the
incidence of metabolic related diseases in
dairy cows showing metabolic abnormalities
during the transition period (altered blood
concentration of b-HOB, NEFA and to a lesser
extent Ca), by administering a commercial
product containing molasses, propylene glycol,
calcium propionate and niacin and selective
treatment with calcium at the time of calving.
The main result of this study shows that ani-
mals that always had levels of NEFA<0.5 and of
b-HOB<1.2 mmol/L (NEGATIVE animals) dur-
ing the pre-partum period are significantly
(P<0.01) less likely to develop one of the dis-
eases monitored (DA, MF, RP or CK) than POS-
ITIVE animals. Group T animals tended to be
less sick and also tended to experience a lower
incidence of DA, MF, RP and CK than those
belonging to group C. Moreover, in the case of
the animals presenting a distinct elevation of
b-HOB or NEFA at any time prior to calving,
the daily administration of a propylene glycol
and calcium propionate-based treatment
(group T) allowed a permanent return to nor-
mal values in 75% of them within 4 to 5 days.
It was generally not possible to observe signif-
icant difference in biochemical results
between the various groups of animals. This
difficulty is ascribed to the great variability of
the individual data and to the small size of
each group, for each period. 
The incidences of the four diseases moni-
tored are those usually reported by the literature
(Goff, 2006; Mulligan et al., 2006; Parker Gaddis
et al., 2012; Vergara et al., 2014), except in the
case of clinical ketosis (CK). For the NEGATIVE
animals the incidence of CK is slightly higher
than those reported in the literature (0 to 5%),
but for the other groups the incidence is more
comparable to that reported for sub-clinical keto-
sis (20 to 40% or even more) (McArt et al.,  2011;
2013, Esposito et al., 2014).
Various blood parameters have been used as
advanced indicators of an energy imbalance (
Stengärde et al., 2010; Hailemariam et al.,
2014). However, NEFA and b-HOB measure-
ments are among the most convenient, as
blood b-HOB can also be measured next to the
cow by means of small portable devices (Free
Style Optium Neo, Abbott Laboratories, CHICA-
GO, IL, USA) (Voyvoda and Erdogan, 2010).
The threshold values chosen for this study are
the same as those used by others (LeBlanc et
al., 2005; McArt et al., 2011, 2012, 2013;
Mulligan et al., 2006).  NEFA and b-HOB levels
provide two measures of the severity of energy
imbalance. Although postpartum diseases
often share risk factors, and these factors may
trigger a cascade of other diseases (Vergara et
al., 2014), it is now well known that this imbal-
ance affects both cows at the start of lactation
and dry cows at the end of gestation and pre-
disposes them to LDA, RP, dystocia, fatty liver,
CK and other problems (Mulligan et al., 2006).
LeBlanc (LeBlanc, 2010) reports that
NEFA>0,4 mmol/L during the 7 to 10 days
before calving multiplies the risk of LDA by 2 to
4 fold and the risk of RP by 2 fold. Likewise, b-
HOB>1,2 mmol/L after calving multiplies the
risk of LDA by 3 to 8 fold and the risk of CK by
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Table 2. Number of cases included in the statistical comparison of results b-HOB grouped
by 3 consecutive days from day -29 to day -2 pre-partum.
Three-days sampling period relative to calving date°                              N of samples
Day -29 (±1 day)                                                                                                         12
Day -26 (±1 day)                                                                                                         26
Day -23 (±1 day)                                                                                                         49
Day -20 (±1 day)                                                                                                         88
Day -17 (±1 day)                                                                                                        134
Day -14 (±1 day)                                                                                                        170
Day -11 (±1 day)                                                                                                        165
Day -8 (±1 day)                                                                                                          143
Day -5 (±1 day)                                                                                                          100
Day -2 (±1 day)                                                                                                           57
°Day-n: n days before calving.
Figure 2. Distribution of pre-partum serum β-HOB values recorded in the whole popu-
lation. Black boxes indicate the I-II interquartile range (IQR), the horizontal line in the
box corresponds to the median, the vertical lines are the limits of outlier distribution
according to the Tukey’s outlier filter rule (|value| >1.5 x IQR). Near outliers are indicat-
ed by the symbols +; far outliers are indicated by the orange asterisks outside the boxes.
Blue diamonds indicate the 95% CI of the mean and the horizontal line in the box the
mean itself.
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4 to 6 fold. The observations reported here fully
agree with those findings, since the NEGATIVE
animals were less (or significantly less) affect-
ed than the POSITIVE animals.
The early detection of sub-clinical ketosis on
the basis of measurements of b-HOB and
NEFA, for the purpose of instituting corrective
treatment and subsequently reducing  the inci-
dence of metabolic related diseases, has
already been proposed by other authors
(Hoedemaker et al., 2004; Overton and
Waldron, 2004; Lomander et al., 2012; McArt et
al., 2012). While it is possible, generally speak-
ing, to have an effect on the serum concentra-
tions of b-HOB and NEFA, the results in
regards the cows’ health, are however, diverse.
Some have ascribed the lack of effectiveness of
such treatments to the fact that the studies are
conducted on herds of high-producing cows, an
objective that can be attained only thanks to
excellent management of the stock, and the
cows can then go through the NEB period with-
out any particular consequences (Hoedemaker
et al., 2004). Overton et Waldron (Overton and
Waldron, 2004) have stated that, in the
absence of proven positive benefits, the rou-
tine administration of propylene glycol is not
recommended.
Conclusions
This study confirms that an aggressive mon-
itoring of pre-partum blood level would help to
identify animals at increased risk to develop a
production disease in the early post-partum.
The proposed on-demand glycogenic treatment
results in mitigating clinical differences
between treated and NEGATIVE animals
whereas differences remain between control
and NEGATIVE animals. Animals with bio-
chemical abnormalities show a noticeable
decrease in the incidence of DA, CK and, in a
lesser extent, RP when treated. However, other
studies involving more aggressive therapeutic
diets and more animals would be worth con-
ducting. 
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